Siteadmin, Check users, nsTeam1RO, nsTeam1RW, nsTeam1_talkRO, nsTeam1_talkRW, oversight, Administrators
30,650
edits
Changes
Jump to navigation
Jump to search
Line 1:
Line 1: + +
I think these are the main points of the controversy
{{draft|HPV vaccination}}
{{draft|HPV vaccination}}
'''Gardasil''' is a controversial [[vaccine]], recently made available by [[Merck]] to prevent infection with the human papillomavirus (HPV) in girls and women ages 9 to 26.<ref>[http://www.gardasil.com/who-should-receive-gardasil.html Who should recieve Gardasil?], Merck official website.</ref> <ref>The vaccine is designed to protect against types 6, 11, 16 and 18 of HPV.</ref>
'''Gardasil''' is a controversial [[vaccine]], recently made available by [[Merck]] to prevent infection with the human papillomavirus (HPV) in girls and women ages 9 to 26.<ref>[http://www.gardasil.com/who-should-receive-gardasil.html Who should recieve Gardasil?], Merck official website.</ref> <ref>The vaccine is designed to protect against types 6, 11, 16 and 18 of HPV.</ref>
Proponents praise it as the first vaccine against cancer. Opponents say it will lead to sexual [[disinhibition]].
These strains of HPV are [[sexually transmitted diseases]] that are endemic among [[promiscuity|promiscuous]] people and have been associated with 70% of cervical cancer cases. They may also play a role in the development of other types of cancer <ref>[http://www.cancer.gov/cancertopics/factsheet/Risk/HPV]</ref>. In June 2006, the U.S. [[Food and Drug Administration]] approved the first HPV vaccine without reviewing any epidemiological studies and monitoring for only a brief period the elevated [[antibody]] levels in recipients of the vaccine.<ref> http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5602a1.htm</ref>
These strains of HPV are [[sexually transmitted diseases]] that are endemic among [[promiscuity|promiscuous]] people and have been associated with 70% of cervical cancer cases. They may also play a role in the development of other types of cancer <ref>[http://www.cancer.gov/cancertopics/factsheet/Risk/HPV]</ref>. In June 2006, the U.S. [[Food and Drug Administration]] approved the first HPV vaccine without reviewing any epidemiological studies and monitoring for only a brief period the elevated [[antibody]] levels in recipients of the vaccine.<ref> http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5602a1.htm</ref>